Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging

dc.contributor.assigneeBaxter Biotech Technology SARLen_US
dc.contributor.assigneeRice Universityen_US
dc.contributor.publisherUnited States Patent and Trademark Officeen_US
dc.creatorWeickert, Michael J.en_US
dc.creatorGlascock, Christopher B.en_US
dc.creatorMathews, Antony J.en_US
dc.creatorLemon, Douglas D.en_US
dc.creatorDoherty, Daniel H.en_US
dc.creatorOlson, John S.en_US
dc.date.accessioned2015-05-04T19:05:40Zen_US
dc.date.available2015-05-04T19:05:40Zen_US
dc.date.filed2002-03-27en_US
dc.date.issued2006-05-23en_US
dc.description.abstractThe invention relates to novel recombinant hemoglobins having reduced nitric oxide scavenging and/or increased high soluble expression. The invention further relates to methods of increasing the soluble expression of recombinant hemoglobin by adding exogenous hemin in molar excess of the heme binding sites of recombinant hemoglobin.en_US
dc.digitization.specificationsThis patent information was downloaded from the US Patent and Trademark website (http://www.uspto.gov/) as image-PDFs. The PDFs were OCRed for access purposes.en_US
dc.format.extent39 ppen_US
dc.identifier.citationWeickert, Michael J., Glascock, Christopher B., Mathews, Antony J., Lemon, Douglas D., Doherty, Daniel H. and Olson, John S., "Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging." Patent US7049406B2. issued 2006-05-23. Retrieved from https://hdl.handle.net/1911/79910.en_US
dc.identifier.patentIDUS7049406B2en_US
dc.identifier.urihttps://hdl.handle.net/1911/79910en_US
dc.language.isoengen_US
dc.titleHemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavengingen_US
dc.typeUtility patenten_US
dc.type.dcmiTexten_US
dc.type.genrepatentsen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
US7049406B2.pdf
Size:
3.59 MB
Format:
Adobe Portable Document Format
Collections